Hantavirus regulation of type i interferon responses

Advances in Virology

Volumn 2012, Issue , 2012, Pages

  Matthys, Valery ^a   MacKow, Erich R ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HANTAVIRUS; PROSPECT HILL VIRUS;

EID: 84873848988     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2012/524024     Document Type: Review

References (111)

1. Johnson K. M., Schmaljohn C. A. N., Hantaviruses: history and overview. Hantaviruses 2001 256 Springer 1 14 (Pubitemid 32016370)
2. Schmaljohn C., Hjelle B., Hantaviruses: a global disease problem. Emerging Infectious Diseases 1997 3 2 95 104 2-s2.0-0031113395 (Pubitemid 127431667)
3. Lee H. W., Hemorrhagic fever with renal syndrome in Korea. Reviews of Infectious Diseases 1989 11 supplement 1 S864 S876 2-s2.0-0024673341
4. Chen J. P., Cosgriff T. M., Hemorrhagic fever virus-induced changes in hemostasis and vascular biology. Blood Coagulation and Fibrinolysis 2000 11 5 461 483 2-s2.0-0033860396 10.1097/00001721-200007000-00010 (Pubitemid 30618527)
5. Lahdevirta J., Clinical features of HFRS in Scandinavia as compared with East Asia. Scandinavian Journal of Infectious Diseases 1982 14 36 93 95 2-s2.0-0020285054 (Pubitemid 13125864)
6. Lähdevirta J., Enger E., Hunderi O. H., Traavik T., Lee H. W., Hantaan virus is related to hemorrhagic fever with renal syndrome in Norway. The Lancet 1982 2 8298 606 2-s2.0-0020480518
7. Penttinen K., Lahdevirta J., Kekomaki R., Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. Journal of Infectious Diseases 1981 143 1 15 21 2-s2.0-0019428334 (Pubitemid 11152592)
8. Zaki S. R., Greer P. W., Coffield L. M., Goldsmith C. S., Nolte K. B., Foucar K., Feddersen R. M., Zumwalt R. E., Miller G. L., Khan A. S., Rollin P. E., Ksiazek T. G., Nichol S. T., Mahy B. W. J., Peters C. J., Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. American Journal of Pathology 1995 146 3 552 579 2-s2.0-0028954686
9. Khan A. S., Young J. C., Hantavirus pulmonary syndrome: at the crossroads. Current Opinion in Infectious Diseases 2001 14 2 205 209 2-s2.0-0035080477 (Pubitemid 32231108)
10. Bustamante E. A., Levy H., Simpson S. Q., Pleural fluid characteristics in hantavirus pulmonary syndrome. Chest 1997 112 4 1133 1136 2-s2.0-0030765730 (Pubitemid 27446346)
11. Duchin J. S., Koster F. T., Peters C. J., Simpson G. L., Tempest B., Zaki S. R., Ksiazek T. G., Rollin P. E., Nichol S., Umland E. T., Moolenaar R. L., Reef S. E., Nolte K. B., Gallaher M. M., Butler J. C., Breiman R. F., Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. New England Journal of Medicine 1994 330 14 949 955 2-s2.0-0028215049 10.1056/NEJM199404073301401 (Pubitemid 24103592)
12. Elliott L. H., Ksiazek T. G., Rollin P. E., Spiropoulou C. F., Morzunov S., Monroe M., Goldsmith C. S., Humphrey C. D., Zaki S. R., Krebs J. W., Maupin G., Gage K., Childs J. E., Nichol S. T., Peters C. J., Isolation of the causative agent of hantavirus pulmonary syndrome. American Journal of Tropical Medicine and Hygiene 1994 51 1 102 108 2-s2.0-0028106801 (Pubitemid 24266295)
13. Nolte K. B., Feddersen R. M., Foucar K., Zaki S. R., Koster F. T., Madar D., Merlin T. L., McFeeley P. J., Umland E. T., Zumwalt R. E., Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Human Pathology 1995 26 1 110 120 2-s2.0-0028796284
14. Schmaljohn C., Bunyaviridae and their replication. Fields Virology 2001 1 4th Lippincott Williams & Wilkins 1581 1602
15. Enria D., Padula P., Segura E. L., Pini N., Edelstein A., Posse C. R., Weissenbacher M. C., Hantavirus pulmonary syndrome in Argentina possibility of person to person transmission. Medicina 1996 56 6 709 711 2-s2.0-0030309519 (Pubitemid 127528617)
16. Gavrilovskaya I., LaMonica R., Fay M. E., Hjelle B., Schmaljohn C., Shaw R., Mackow E. R., New York 1 and sin nombre viruses are serotypically distinct viruses associated with hantavirus pulmonary syndrome. Journal of Clinical Microbiology 1999 37 1 122 126 2-s2.0-0032923426 (Pubitemid 29004191)
17. Hjelle B., Lee S. W., Song W., Torrez-Martinez N., Song J. W., Yanagihara R., Gavrilovskaya I., Mackow E. R., Molecular linkage of hantavirus pulmonary syndrome to the white-fooled mouse, Peromyscus leucopus: genetic characterization of the M genome of New York virus. Journal of Virology 1995 69 12 8137 8141 2-s2.0-0028822214
18. Nichol S. T., Spiropoulou C. F., Morzunov S., Rollin P. E., Ksiazek T. G., Feldmann H., Sanchez A., Childs J., Zaki S., Peters C. J., Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993 262 5135 914 917 2-s2.0-0027910025 (Pubitemid 24014083)
19. Schmaljohn A. L., Li D., Negley D. L., Bressler D. S., Turell M. J., Korch G. W., Ascher S., Ascher S., Schmaljohn C. S., Isolation and initial characterization of a newfound hantavirus from California. Virology 1995 206 2 963 972 2-s2.0-0028861659 10.1006/viro.1995.1019
20. Song J. W., Baek L. J., Carleton Gajdusek D., Yanagihara R., Gavrilovskaya I., Luft B. J., Mackow E. R., Hjelle B., Isolation of pathogenic hantavirus from white-footed mouse (Peromyscus leucopus). The Lancet 1994 344 8937 1637 2-s2.0-0028126901 (Pubitemid 24365370)
21. Galeno H., Mora J., Villagra E., Fernandez J., Hernandez J., Mertz G. J., Ramirez E., First human isolate of hantavirus (Andes virus) in the Americas. Emerging Infectious Diseases 2002 8 7 657 661 2-s2.0-0036310720 (Pubitemid 34764728)
22. López N., Padula P., Rossi C., Miguel S., Edelstein A., Ramírez E., Franze-Fernández M. T., Genetic characterization and phylogeny of andes virus and variants from Argentina and Chile. Virus Research 1997 50 1 77 84 2-s2.0-0342460489 10.1016/S0168-1702(97)00053-1 (Pubitemid 27283256)
23. Martinez V. P., Bellomo C., San Juan J., Pinna D., Forlenza R., Elder M., Padula P. J., Person-to-person transmission of Andes virus. Emerging Infectious Diseases 2005 11 12 1848 1853 2-s2.0-33644820885 (Pubitemid 43356079)
24. Padula P. J., Edelstein A., Miguel S. D. L., López N. M., Rossi C. M., Rabinovich R. D., Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 1998 241 2 323 330 2-s2.0-0032519398 10.1006/viro.1997.8976 (Pubitemid 28384205)
25. Plyusnin A., Vapalahti O., Lankinen H., Lehvaslaiho H., Apekina N., Myasnikov Y., Kallio-Kokko H., Henttonen H., Lundkvist A., Brummer-Korvenkontio M., Gavrilovskaya I., Vaheri A., Tula virus: a newly detected hantavirus carried by European common voles. Journal of Virology 1994 68 12 7833 7839 2-s2.0-0027937971 (Pubitemid 24362670)
26. Vapalahti O., Lundkvist S. K., Kukkonen S. K. J., Cheng Y., Gilljam M., Kanerva M., Manni T., Pejcoch M., Niemimaa J., Kaikusalo A., Henttonen H., Vaheri A., Plyusnin A., Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. Journal of General Virology 1996 77 12 3063 3067 2-s2.0-8044244820 (Pubitemid 27056526)
27. Kraus A. A., Raftery M. J., Giese T., Ulrich R., Zawatzky R., Hippenstiel S., Suttorp N., Krüger D. H., Schönrich G., Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. Journal of Virology 2004 78 12 6143 6150 2-s2.0-2642567552 10.1128/JVI.78.12.6143-6150.2004 (Pubitemid 38715912)
28. Yanagihara R., Daum C. A., Lee P. W., Baek L. J., Amyx H. L., Gajdusek D. C., Gibbs C. J., Serological survey of Prospect Hill virus infection in indigenous wild rodents in the USA. Transactions of the Royal Society of Tropical Medicine and Hygiene 1987 81 1 42 45 2-s2.0-0023461113
29. Yanagihara R., Silverman D. J., Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Archives of Virology 1990 111 3-4 281 286 2-s2.0-0025108236 10.1007/BF01311063 (Pubitemid 20289379)
30. Pensiero M. N., Sharefkin J. B., Dieffenbach C. W., Hay J., Hantaan virus infection of human endothelial cells. Journal of Virology 1992 66 10 5929 5936 2-s2.0-0026731010
31. Clement J. P., Hantavirus. Antiviral Research 2003 57 1-2 121 127 2-s2.0-0037285328 10.1016/S0166-3542(02)00205-X (Pubitemid 36254726)
32. Plyusnin A., Morzunov S. P., Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Current Topics in Microbiology and Immunology 2000 256 47 75 2-s2.0-0034533984 (Pubitemid 32016373)
33. Tischler N. D., Galeno H., Rosemblatt M., Valenzuela P. D. T., Human and rodent humoral immune responses to Andes virus structural proteins. Virology 2005 334 2 319 326 2-s2.0-15244356846 10.1016/j.virol.2005.01.031 (Pubitemid 40386966)
34. Hepojoki J., Strandin T., Wang H., Vapalahti O., Vaheri A., Lankinen H., Cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein. Journal of General Virology 2010 91 9 2341 2350 2-s2.0-77954217973 10.1099/vir.0.021006-0
35. Kaukinen P., Vaheri A., Plyusnin A., Hantavirus nucleocapsid protein: a multifunctional molecule with both housekeeping and ambassadorial duties. Archives of Virology 2005 150 9 1693 1713 2-s2.0-23844454526 10.1007/s00705-005-0555-4 (Pubitemid 41176630)
36. Virtanen J. O., Jaaskelainen K. M., Djupsjöbacka J., Vaheri A., Plyusnin A., Tula hantavirus NSs protein accumulates in the perinuclear area in infected and transfected cells. Archives of Virology 2010 155 1 117 121 2-s2.0-74849110199 10.1007/s00705-009-0546-y
37. Jaaskelainen K. M., Plyusnina A., Lundkvist S. K., Vaheri A., Plyusnin A., Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF. Virology Journal 2008 5, article 3 2-s2.0-39749198316 10.1186/1743-422X-5-3 (Pubitemid 351303216)
38. Schmaljohn C. S., Schmaljohn A. L., Dalrymple J. M., Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order. Virology 1987 157 1 31 39 2-s2.0-0023092796 (Pubitemid 17029979)
39. Pensiero M. N., Hay J., The Hantaan virus M-segment glycoproteins G1 and G2 can be expressed independently. Journal of Virology 1992 66 4 1907 1914 2-s2.0-0026583829
40. Pensiero M. N., Jennings G. B., Schmaljohn C. S., Hay J., Expression of the Hantaan virus M genome segment by using a vaccinia virus recombinant. Journal of Virology 1988 62 3 696 702 2-s2.0-0023836515 (Pubitemid 18068623)
41. Löber C., Anheier B., Lindow S., Klenk H. D., Feldmann H., The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology 2001 289 2 224 229 2-s2.0-0035950598 10.1006/viro.2001.1171 (Pubitemid 33141002)
42. Kamrud K. I., Schmaljohn C. S., Expression strategy of the M genome segment of Hantaan virus. Virus Research 1994 31 1 109 121 2-s2.0-0028008809 10.1016/0168-1702(94)90074-4 (Pubitemid 24043461)
43. Deyde V. M., Rizvanov A. A., Chase J., Otteson E. W., Jeor S. C. S., Interactions and trafficking of Andes and Sin Nombre Hantavirus glycoproteins G1 and G2. Virology 2005 331 2 307 315 2-s2.0-11344292598 10.1016/j.virol.2004.11. 003 (Pubitemid 40075457)
44. Antic D., Wright K. E., Kang C. Y., Maturation of Hantaan virus glycoproteins G1 and G2. Virology 1992 189 1 324 328 2-s2.0-0026625276 10.1016/0042-6822(92)90709-X
45. Tischler N. D., Gonzales A., Perez-Acle T., Rosemblatt M., Valenzuela P. D. T., Hantavirus Gc glycoprotein: evidence for a class ll fusion protein. Journal of General Virology 2005 86 11 2937 2947 2-s2.0-27644471666 10.1099/vir.0.81083-0 (Pubitemid 41555557)
46. Spiropoulou C. F., Goldsmith C. S., Shoemaker T. R., Peters C. J., Compans R. W., Sin Nombre virus glycoprotein trafficking. Virology 2003 308 1 48 63 2-s2.0-0345269271 10.1016/S0042-6822(02)00092-2 (Pubitemid 36428964)
47. Geimonen E., Fernandez I., Gavrilovskaya I. N., Mackow E. R., Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail. Journal of Virology 2003 77 20 10760 10768 2-s2.0-0141677743 10.1128/JVI.77.20.10760-10768.2003 (Pubitemid 37204269)
48. Geimonen E., LaMonica R., Springer K., Farooqui Y., Gavrilovskaya I. N., Mackowl E. R., Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. Journal of Virology 2003 77 2 1638 1643 2-s2.0-0037223724 10.1128/JVI.77.2.1638-1643.2003 (Pubitemid 36055588)
49. Alff P. J., Gavrilovskaya I. N., Gorbunova E., Endriss K., Chong Y., Geimonen E., Sen N., Reich N. C., Mackow E. R., The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I-and TBK-1-directed interferon responses. Journal of Virology 2006 80 19 9676 9686 2-s2.0-33748923334 10.1128/JVI.00508-06 (Pubitemid 44435642)
50. Alff P. J., Sen N., Gorbunova E., Gavrilovskaya I. N., Mackow E. R., The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. Journal of Virology 2008 82 18 9115 9122 2-s2.0-50949085475 10.1128/JVI.00290-08
51. Matthys V., Gorbunova E. E., Gavrilovskaya I. N., Pepini T., Mackow E. R., The C-terminal 42 residues of the tula virus Gn protein regulate interferon induction. Journal of Virology 2011 85 10 4752 4760 2-s2.0-79955414003 10.1128/JVI.01945-10
52. Sen N., Sen A., Mackow E. R., Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation. Journal of Virology 2007 81 8 4323 4330 2-s2.0-34247097542 10.1128/JVI.02279-06 (Pubitemid 46586926)
53. Wang H., Strandin T., Hepojoki J., Lankinen H., Vaheri A., Degradation and aggresome formation of the Gn tail of the apathogenic Tula hantavirus. Journal of General Virology 2009 90 12 2995 3001 2-s2.0-70849123017 10.1099/vir.0.012179-0
54. Seth R. B., Sun L., Chen Z. J., Antiviral innate immunity pathways. Cell Research 2006 16 2 141 147 2-s2.0-32644456874 10.1038/sj.cr.7310019 (Pubitemid 43247969)
55. Stark G. R., Kerr I. M., Williams B. R. G., Silverman R. H., Schreiber R. D., How cells respond to interferons. Annual Review of Biochemistry 1998 67 227 264 2-s2.0-0031657551 10.1146/annurev.biochem.67.1.227 (Pubitemid 28411130)
56. Meylan E., Tschopp J., Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Molecular Cell 2006 22 5 561 569 2-s2.0-33744539798 10.1016/j.molcel.2006.05.012 (Pubitemid 43817607)
57. Yoneyama M., Fujita T., RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine and Growth Factor Reviews 2007 18 5-6 545 551 2-s2.0-34548126512 10.1016/j.cytogfr.2007.06.023 (Pubitemid 47302820)
58. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunology 2004 5 7 730 737 2-s2.0-3242813113 10.1038/ni1087 (Pubitemid 39023305)
59. Barber G. N., Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Current Opinion in Immunology 2011 23 1 10 20 2-s2.0-79951679142 10.1016/j.coi.2010.12.015
60. Bowie A., The STING in the tail for cytosolic DNA-dependent activation of IRF3. Science Signaling 2012 5 214 pe9 2-s2.0-84857938324 10.1126/scisignal. 2002919
61. Ishikawa H., Barber G. N., STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008 455 7213 674 678 2-s2.0-53349178089 10.1038/nature07317
62. Ishikawa H., Barber G. N., The STING pathway and regulation of innate immune signaling in response to DNA pathogens. Cellular and Molecular Life Sciences 2011 68 7 1157 1165 2-s2.0-79953705058 10.1007/s00018-010-0605-2
63. Ishikawa H., Ma Z., Barber G. N., STING regulates intracellular DNA-mediated, type i interferon-dependent innate immunity. Nature 2009 461 7265 788 792 2-s2.0-70349943834 10.1038/nature08476
64. Ouyang S., Song X., Wang Y., Ru H., Shaw N., Jiang Y., Niu F., Zhu Y., Qiu W., Parvatiyar K., Li Y., Zhang R., Cheng G., Liu Z.-J., Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity 2012 36 6 1073 1086 2-s2.0-84863009492 10.1016/j.immuni.2012.03.019
65. Tanaka Y., Chen Z. J., STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Science Signaling 2012 5 214 ra20 2-s2.0-84857937262 10.1126/scisignal.2002521
66. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K. J., Takeuchi O., Akira S., IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunology 2005 6 10 981 988 2-s2.0-27144440523 10.1038/ni1243 (Pubitemid 41486182)
67. Saha S. K., Pietras E. M., He J. Q., Kang J. R., Liu S. Y., Oganesyan G., Shahangian A., Zarnegar B., Shiba T. L., Wang Y., Cheng G., Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO Journal 2006 25 14 3257 3263 2-s2.0-33746479050 10.1038/sj.emboj.7601220 (Pubitemid 44141784)
68. Yoneyama M., Fujita T., Function of RIG-I-like receptors in antiviral innate immunity. Journal of Biological Chemistry 2007 282 21 15315 15318 2-s2.0-34447560071 10.1074/jbc.R700007200 (Pubitemid 47093255)
69. He L., Grammer A. C., Wu X., Lipsky P. E., TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF- B activation. Journal of Biological Chemistry 2004 279 53 55855 55865 2-s2.0-11244334124 10.1074/jbc.M407284200 (Pubitemid 40066593)
70. Hoebe K., Beutler B., TRAF3: a new component of the TLR-signaling apparatus. Trends in Molecular Medicine 2006 12 5 187 189 2-s2.0-33646746802 10.1016/j.molmed.2006.03.008 (Pubitemid 43744375)
71. Oganesyan G., Saha S. K., Guo B., He J. Q., Shahangian A., Zarnegar B., Perry A., Cheng G., Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006 439 7073 208 211 2-s2.0-30544447047 10.1038/nature04374 (Pubitemid 43083142)
72. Saha S. K., Cheng G., TRAF3: a new regulator of type I interferons. Cell Cycle 2006 5 8 804 807 2-s2.0-33746611639 (Pubitemid 44145571)
73. Fitzgerald K. A., McWhirter S. M., Faia K. L., Rowe D. C., Latz E., Golenbock D. T., Coyle A. J., Liao S. M., Maniatis T., IKKE and TBKI are essential components of the IRF3 signalling pathway. Nature Immunology 2003 4 5 491 496 2-s2.0-0038393016 10.1038/ni921 (Pubitemid 36592443)
74. Chau T. L., Gioia R., Gatot J. S., Patrascu F., Carpentier I., Chapelle J. P., O'Neill L., Beyaert R., Piette J., Chariot A., Are the IKKs and IKK-related kinases TBK1 and IKK- ε similarly activated? Trends in Biochemical Sciences 2008 33 4 171 180 2-s2.0-41549165085 10.1016/j.tibs.2008. 01.002
75. Parvatiyar K., Barber G. N., Harhaj E. W., TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. Journal of Biological Chemistry 2010 285 20 14999 15009 2-s2.0-77952060367 10.1074/jbc.M110.109819
76. Pomerantz J. L., Baltimore D., NF- B activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO Journal 1999 18 23 6694 6704 2-s2.0-0033485542
77. Rani M. R. S., Ransohoff R. M., Alternative and accessory pathways in the regulation of IFN- β -mediated gene expression. Journal of Interferon and Cytokine Research 2005 25 12 788 798 2-s2.0-30344483167 10.1089/jir.2005.25.788 (Pubitemid 43068490)
78. Darnell J. E., Kerr I. M., Stark G. R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994 264 5164 1415 1421 2-s2.0-0028234529 (Pubitemid 24217131)
79. Schindler C., Darnell J. E., Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annual Review of Biochemistry 1995 64 621 651 2-s2.0-0029069145
80. Shang G., Zhu D., Li N., Zhang J., Zhu C., Lu D., Liu C., Yu Q., Zhao Y., Xu S., Gu L., Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP. Nature Structural and Molecular Biology 2012 19 725 727 2-s2.0-84862503679 10.1038/nsmb.2332
81. Khaiboullina S. F., Rizvanov A. A., Deyde V. M., Jeor S. C. S., Andes virus stimulates interferon-inducible MxA protein expression in endothelial cells. Journal of Medical Virology 2005 75 2 267 275 2-s2.0-11144230448 10.1002/jmv.20266 (Pubitemid 40053738)
82. Kanerva M., Mustonen J., Vaheri A., Pathogenesis of Puumala and other hantavirus infections. Reviews in Medical Virology 1998 8 2 67 86 2-s2.0-0031834432 10.1002/(SICI)1099-1654(199804/06)8:2<67::AID-RMV217>3. 0.CO;2-U (Pubitemid 28288156)
83. Frese M., Kochs G., Feldmann H., Hertkorn C., Haller O., Inhibition of Bunyaviruses, Phleboviruses, and Hantaviruses by human MxA protein. Journal of Virology 1996 70 2 915 923 2-s2.0-0029671215
84. Jonsson C. B., Hooper J., Mertz G., Treatment of hantavirus pulmonary syndrome. Antiviral Research 2008 78 1 162 169 2-s2.0-40749139151 10.1016/j.antiviral.2007.10.012
85. Tamura M., Asada H., Kondo K., Takahashi M., Yamanishi K., Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). Antiviral Research 1987 8 4 171 178 2-s2.0-0023607218 (Pubitemid 18032859)
86. Jonsson C. B., Figueiredo L. T. M., Vapalahti O., A global perspective on hantavirus ecology, epidemiology, and disease. Clinical Microbiology Reviews 2010 23 2 412 441 2-s2.0-77950651664 10.1128/CMR.00062-09
87. Geimonen E., Neff S., Raymond T., Kocer S. S., Gavrilovskaya I. N., Mackow E. R., Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proceedings of the National Academy of Sciences of the United States of America 2002 99 21 13837 13842 2-s2.0-0037109041 10.1073/pnas.192298899 (Pubitemid 35215467)
88. Prescott J., Ye C., Sen G., Hjelle B., Induction of innate immune response genes by sin nombre hantavirus does not require viral replication. Journal of Virology 2005 79 24 15007 15015 2-s2.0-29744439230 10.1128/JVI.79.24.15007-15015.2005 (Pubitemid 43032282)
89. Spiropoulou C. F., Albariño C. G., Ksiazek T. G., Rollin P. E., Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. Journal of Virology 2007 81 6 2769 2776 2-s2.0-33947414442 10.1128/JVI.02402-06 (Pubitemid 46447041)
90. Shim S. H., Park M.-S., Moon S., Park K. S., Song J.-W., Song K.-J., Baek L. J., Comparison of innate immune responses to pathogenic and putative non-pathogenic hantaviruses in vitro. Virus Research 2011 160 1-2 367 373 2-s2.0-81155161012 10.1016/j.virusres.2011.07.013
91. Emeny J. M., Morgan M. J., Regulation of the interferon system: evidence that vero cells have a genetic defect in interferon production. Journal of General Virology 1979 43 1 247 252 2-s2.0-0018756890 (Pubitemid 9181666)
92. Wathelet M. G., Berr P. M., Huez G. A., Regulation of gene expression by cytokines and virus in human cells lacking the type-I interferon locus. European Journal of Biochemistry 1992 206 3 901 910 2-s2.0-0026647985 10.1111/j.1432-1033.1992.tb16999.x
93. Jaaskelainen K. M., Kaukinen P., Minskaya E. S., Plyusnina A., Vapalahti O., Elliott R. M., Weber F., Vaheri A., Plyusnin A., Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. Journal of Medical Virology 2007 79 10 1527 1536 2-s2.0-34548245061 10.1002/jmv.20948 (Pubitemid 47328742)
94. Levine J. R., Prescott J., Brown K. S., Best S. M., Ebihara H., Feldmann H., Antagonism of type I interferon responses by new world hantaviruses. Journal of Virology 2010 84 22 11790 11801 2-s2.0-78049487802 10.1128/JVI.00916-10
95. Taylor S. L., Frias-Staheli N., García-Sastre A., Schmaljohn C. S., Hantaan virus nucleocapsid protein binds to importin α proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. Journal of Virology 2009 83 3 1271 1279 2-s2.0-59749104967 10.1128/JVI.00986-08
96. Taylor S. L., Krempel R. L., Schmaljohn C. S., Inhibition of TNF- α -induced Activation of NF- B by hantavirus nucleocapsid proteins. Annals of the New York Academy of Sciences 2009 1171 supplement 1 E86 E93 2-s2.0-70350482816 10.1111/j.1749-6632.2009.05049.x
97. Billecocq A., Spiegel M., Vialat P., Kohl A., Weber F., Bouloy M., Haller O., NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. Journal of Virology 2004 78 18 9798 9806 2-s2.0-4444374579 10.1128/JVI.78.18.9798-9806.2004 (Pubitemid 39187098)
98. Blakqori G., Delhaye S., Habjan M., Blair C. D., Sánchez-Vargas I., Olson K. E., Attarzadeh-Yazdi G., Fragkoudis R., Kohl A., Kalinke U., Weiss S., Michiels T., Staeheli P., Weber F., La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. Journal of Virology 2007 81 10 4991 4999 2-s2.0-34248333002 10.1128/JVI.01933-06 (Pubitemid 46744411)
99. Bouloy M., Janzen C., Vialat P., Khun H., Pavlovic J., Huerre M., Haller O., Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs. Journal of Virology 2001 75 3 1371 1377 2-s2.0-0035152344 10.1128/JVI.75.3.1371-1377.2001 (Pubitemid 32094695)
100. Weber F., Bridgen A., Fazakerley J. K., Streitenfeld H., Kessler N., Randall R. E., Elliott R. M., Bunyamwera Bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. Journal of Virology 2002 76 16 7949 7955 2-s2.0-0036311874 10.1128/JVI.76.16.7949-7955.2002 (Pubitemid 34809048)
101. Häcker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L. C., Wang G. G., Kamps M. P., Raz E., Wagner H., Häcker G., Mann M., Karin M., Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006 439 7073 204 207 2-s2.0-30544451546 10.1038/nature04369 (Pubitemid 43083141)
102. Ely K. R., Li C., Structurally adaptive hot spots at a protein interaction interface on TRAF3. Journal of Molecular Recognition 2002 15 5 286 290 2-s2.0-0036760956 10.1002/jmr.589 (Pubitemid 35409332)
103. He J. Q., Saha S. K., Kang J. R., Zarnegar B., Cheng G., Specificity of TRAF3 in its negative regulation of the noncanonical NF- B pathway. Journal of Biological Chemistry 2007 282 6 3688 3694 2-s2.0-33947506490 10.1074/jbc.M610271200 (Pubitemid 47084476)
104. Li C., Ni C. Z., Havert M. L., Cabezas E., He J., Kaiser D., Reed J. C., Satterthwait A. C., Cheng G., Ely K. R., Downstream regulator TANK binds to the CD40 recognition site on TRAF3. Structure 2002 10 3 403 411 2-s2.0-18344384218 10.1016/S0969-2126(02)00733-5 (Pubitemid 34230627)
105. Gavrilovskaya I. N., Gorbunova E. E., Mackow N. A., Mackow E. R., Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. Journal of Virology 2008 82 12 5797 5806 2-s2.0-44949117721 10.1128/JVI.02397-07 (Pubitemid 351822254)
106. Gavrilovskaya I. N., Gorbunova E. E., Mackow E. R., Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. Journal of Virology 2010 84 9 4832 4839 2-s2.0-77950813111 10.1128/JVI.02405-09
107. Gorbunova E., Gavrilovskaya I. N., Mackow E. R., Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cell. Journal of Virology 2010 84 14 7405 7411 2-s2.0-77953763318 10.1128/JVI.00576-10
108. Kayagaki N., Phung Q., Chan S., Chaudhari R., Quan C., O'Rourke K. M., Eby M., Pietras E., Cheng G., Bazan J. F., Zhang Z., Arnott D., Dixit V. M., DUBA: a deubiquitinase that regulates type I interferon production. Science 2007 318 5856 1628 1632 2-s2.0-36448943427 10.1126/science.1145918 (Pubitemid 350233662)
109. Gavrilovskaya I. N., Peresleni T., Geimonen E., Mackow E. R., Pathogenic hantaviruses selectively inhibit β 3 integrin directed endothelial cell migration. Archives of Virology 2002 147 10 1913 1931 2-s2.0-0036402322 10.1007/s00705-002-0852-0 (Pubitemid 35218716)
110. Gavrilovskaya I. N., Shepley M., Shaw R., Ginsberg M. H., Mackow E. R., β 3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proceedings of the National Academy of Sciences of the United States of America 1998 95 12 7074 7079 2-s2.0-0032499532 10.1073/pnas.95.12.7074 (Pubitemid 28278109)
111. Gavrilovskaya I. N., Brown E. J., Ginsberg M. H., Mackow E. R., Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by β 3 integrins. Journal of Virology 1999 73 5 3951 3959 2-s2.0-0032946942 (Pubitemid 29189839)